• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎、细胞因子、炎症与香料:它们之间有何关联?

COVID-19, cytokines, inflammation, and spices: How are they related?

机构信息

Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India.

Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India.

出版信息

Life Sci. 2021 Nov 1;284:119201. doi: 10.1016/j.lfs.2021.119201. Epub 2021 Feb 16.

DOI:10.1016/j.lfs.2021.119201
PMID:33607159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884924/
Abstract

BACKGROUND

Cytokine storm is the exaggerated immune response often observed in viral infections. It is also intimately linked with the progression of COVID-19 disease as well as associated complications and mortality. Therefore, targeting the cytokine storm might help in reducing COVID-19-associated health complications. The number of COVID-19 associated deaths (as of January 15, 2021; https://www.worldometers.info/coronavirus/) in the USA is high (1199/million) as compared to countries like India (110/million). Although the reason behind this is not clear, spices may have some role in explaining this difference. Spices and herbs are used in different traditional medicines, especially in countries such as India to treat various chronic diseases due to their potent antioxidant and anti-inflammatory properties.

AIM

To evaluate the literature available on the anti-inflammatory properties of spices which might prove beneficial in the prevention and treatment of COVID-19 associated cytokine storm.

METHOD

A detailed literature search has been conducted on PubMed for collecting information pertaining to the COVID-19; the history, origin, key structural features, and mechanism of infection of SARS-CoV-2; the repurposed drugs in use for the management of COVID-19, and the anti-inflammatory role of spices to combat COVID-19 associated cytokine storm.

KEY FINDINGS

The literature search resulted in numerous in vitro, in vivo and clinical trials that have reported the potency of spices to exert anti-inflammatory effects by regulating crucial molecular targets for inflammation.

SIGNIFICANCE

As spices are derived from Mother Nature and are inexpensive, they are relatively safer to consume. Therefore, their anti-inflammatory property can be exploited to combat the cytokine storm in COVID-19 patients. This review thus focuses on the current knowledge on the role of spices for the treatment of COVID-19 through suppression of inflammation-linked cytokine storm.

摘要

背景

细胞因子风暴是一种在病毒感染中经常观察到的过度免疫反应,它与 COVID-19 疾病的进展以及相关并发症和死亡率密切相关。因此,靶向细胞因子风暴可能有助于减少 COVID-19 相关的健康并发症。截至 2021 年 1 月 15 日(https://www.worldometers.info/coronavirus/),美国与 COVID-19 相关的死亡人数(每百万 1199 人)很高,而印度等国家(每百万 110 人)则相对较低。尽管背后的原因尚不清楚,但香料可能在解释这一差异方面发挥了一些作用。香料和草药被用于不同的传统医学中,特别是在印度等国家,由于其具有强大的抗氧化和抗炎特性,用于治疗各种慢性疾病。

目的

评估有关香料抗炎特性的现有文献,这些特性可能有助于预防和治疗 COVID-19 相关的细胞因子风暴。

方法

在 PubMed 上进行了详细的文献检索,以收集有关 COVID-19 的信息;SARS-CoV-2 的历史、起源、关键结构特征和感染机制;用于 COVID-19 管理的已重新使用药物,以及香料在抗击 COVID-19 相关细胞因子风暴方面的抗炎作用。

主要发现

文献检索结果显示,许多体外、体内和临床试验报告称,香料通过调节炎症的关键分子靶点发挥抗炎作用。

意义

由于香料源自大自然,价格低廉,因此相对更安全。因此,可以利用它们的抗炎特性来对抗 COVID-19 患者的细胞因子风暴。因此,本综述重点关注通过抑制炎症相关细胞因子风暴来治疗 COVID-19 的香料的当前知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/a40cd6897eb4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/c7253a154de3/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/e413f2b776d1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/a2af90b07eac/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/8e1a9fabf8a8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/a40cd6897eb4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/c7253a154de3/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/e413f2b776d1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/a2af90b07eac/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/8e1a9fabf8a8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1b/7884924/a40cd6897eb4/gr4_lrg.jpg

相似文献

1
COVID-19, cytokines, inflammation, and spices: How are they related?新型冠状病毒肺炎、细胞因子、炎症与香料:它们之间有何关联?
Life Sci. 2021 Nov 1;284:119201. doi: 10.1016/j.lfs.2021.119201. Epub 2021 Feb 16.
2
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.COVID-19 中的细胞因子风暴:从病毒感染到免疫反应、诊断和治疗。
Int J Biol Sci. 2022 Jan 1;18(2):459-472. doi: 10.7150/ijbs.59272. eCollection 2022.
3
Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases.感染性疾病引起的细胞因子风暴的发病机制与治疗。
Int J Mol Sci. 2021 Nov 30;22(23):13009. doi: 10.3390/ijms222313009.
4
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?炎症消退:避免 COVID-19 中细胞因子风暴的双管齐下策略?
Cancer Metastasis Rev. 2020 Jun;39(2):337-340. doi: 10.1007/s10555-020-09889-4.
5
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.有前景的药物再利用方法针对与 SARS-CoV-2 并发症相关的细胞因子风暴。
Immunopharmacol Immunotoxicol. 2021 Aug;43(4):395-409. doi: 10.1080/08923973.2021.1931302. Epub 2021 May 31.
6
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害:综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
7
Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.寄生虫以依赖白细胞介素 9 的方式缓解 COVID-19 相关细胞因子风暴。
mBio. 2024 Jun 12;15(6):e0090524. doi: 10.1128/mbio.00905-24. Epub 2024 May 10.
8
Immunopathogenesis and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的免疫发病机制与治疗。
Theranostics. 2021 Jan 1;11(1):316-329. doi: 10.7150/thno.49713. eCollection 2021.
9
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".COVID-19 感染老年患者细胞因子风暴的可能病理生理学机制:“炎症性衰老”的作用。
Inflamm Res. 2020 Sep;69(9):825-839. doi: 10.1007/s00011-020-01372-8. Epub 2020 Jun 11.
10
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.

引用本文的文献

1
Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management.调控调控因子:长链非编码RNA作为慢性疾病管理中的自噬调控因子
J Biomed Sci. 2024 Dec 23;31(1):105. doi: 10.1186/s12929-024-01092-9.
2
Demyelination in Patients with POST-COVID Depression.新冠后抑郁症患者的脱髓鞘病变
J Clin Med. 2024 Aug 9;13(16):4692. doi: 10.3390/jcm13164692.
3
CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis.CD147 介导 SARS-CoV-2 刺突蛋白伪病毒感染及其诱导精原细胞凋亡。

本文引用的文献

1
Informing the pandemic response: the role of the WHO's COVID-19 Weekly Epidemiological Update.为大流行应对提供信息:世界卫生组织《COVID-19 每周流行病学更新》的作用。
BMJ Glob Health. 2024 Apr 4;9(4):e014466. doi: 10.1136/bmjgh-2023-014466.
2
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.抗 HCV 药物达卡他韦和索非布韦对 COVID-19 病因 SARS-CoV-2 的体外抗病毒活性。
J Antimicrob Chemother. 2021 Jun 18;76(7):1874-1885. doi: 10.1093/jac/dkab072.
3
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
Endocrine. 2024 Sep;85(3):1435-1445. doi: 10.1007/s12020-024-03891-4. Epub 2024 Jun 1.
4
COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas.新型冠状病毒肺炎与疟疾合并感染:流行地区临床结局的系统评价
PeerJ. 2024 Apr 18;12:e17160. doi: 10.7717/peerj.17160. eCollection 2024.
5
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome.中性粒细胞明胶酶相关脂质运载蛋白作为急性后新冠综合征的生物标志物
J Clin Med. 2024 Mar 23;13(7):1851. doi: 10.3390/jcm13071851.
6
Association of dietary inflammatory index and the SARS-CoV-2 infection incidence, severity and mortality of COVID-19: a systematic review and dose-response meta-analysis.膳食炎症指数与 SARS-CoV-2 感染 COVID-19 的发病率、严重程度和死亡率的关联:系统评价和剂量反应荟萃分析。
Nutr J. 2024 Feb 20;23(1):21. doi: 10.1186/s12937-024-00927-3.
7
A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.一种新型载姜黄素的薄膜喷雾能抑制 SARS-CoV-2 和流感病毒感染并增强黏膜免疫。
Virol J. 2024 Jan 23;21(1):26. doi: 10.1186/s12985-023-02282-x.
8
Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study.趋化因子和生长因子水平的变化可能是监测 COVID-19 患者疾病严重程度的有用生物标志物;一项初步研究。
Front Immunol. 2024 Jan 4;14:1320362. doi: 10.3389/fimmu.2023.1320362. eCollection 2023.
9
The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.与新型冠状病毒肺炎患者疾病严重程度及不良预后相关的免疫炎症因子:一项回顾性队列研究
Heliyon. 2023 Dec 12;10(1):e23583. doi: 10.1016/j.heliyon.2023.e23583. eCollection 2024 Jan 15.
10
Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity.揭开新冠病毒的秘密:利用细胞因子作为诊断和预测严重程度的强大生物标志物
J Inflamm Res. 2023 Dec 11;16:6055-6070. doi: 10.2147/JIR.S439217. eCollection 2023.
甲磺酸卡莫司他通过 TMPRSS2 相关蛋白酶抑制 SARS-CoV-2 的激活,其代谢产物 GBPA 发挥抗病毒活性。
EBioMedicine. 2021 Mar;65:103255. doi: 10.1016/j.ebiom.2021.103255. Epub 2021 Mar 4.
4
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein.菠萝蛋白酶通过靶向血管紧张素转换酶2(ACE-2)、跨膜丝氨酸蛋白酶2(TMPRSS2)和刺突蛋白来抑制新型冠状病毒2(SARS-CoV-2)感染。
Clin Transl Med. 2021 Feb;11(2):e281. doi: 10.1002/ctm2.281.
5
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.二甲双胍治疗 COVID-19 住院患者的死亡率风险:一项回顾性队列分析。
Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3.
6
Micronutrients and bioactive substances: Their potential roles in combating COVID-19.微量营养素和生物活性物质:它们在抗击 COVID-19 中的潜在作用。
Nutrition. 2021 Apr;84:111103. doi: 10.1016/j.nut.2020.111103. Epub 2020 Dec 4.
7
Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial.口服纳米姜黄素制剂治疗轻至中度住院的冠状病毒病-19患者的疗效:一项开放标签非随机临床试验。
Phytother Res. 2021 May;35(5):2616-2623. doi: 10.1002/ptr.7004. Epub 2021 Jan 3.
8
Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.TMPRSS2 基因的结构变异、表达谱和药物遗传学特性作为 COVID-19 治疗的潜在靶点。
Genes (Basel). 2020 Dec 25;12(1):19. doi: 10.3390/genes12010019.
9
analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection.分析植物化学物质作为潜在的 SARS-CoV-2 感染相关蛋白酶抑制剂。
J Biomol Struct Dyn. 2022 Jul;40(11):5053-5059. doi: 10.1080/07391102.2020.1866669. Epub 2020 Dec 29.
10
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.纳米姜黄素对轻、重症 COVID-19 患者 Th17 细胞反应的免疫调节作用。
J Cell Physiol. 2021 Jul;236(7):5325-5338. doi: 10.1002/jcp.30233. Epub 2020 Dec 28.